KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
14,850
-30 (-0.20%)
Last updated: Aug 14, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 161.96 billion as of August 15, 2025. Its market cap has decreased by -17.50% in one year.
Market Cap
161.96B
Enterprise Value
150.44B
Revenue
81.78B
Ranking
n/a
PE Ratio
54.20
Stock Price
14,850.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 161.96B, a decrease of -11.87%. That is a compound annual growth rate of -2.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 161.96B | -3.00% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 467.88T |
SK hynix | 190.88T |
LG Energy Solution | 92.20T |
Samsung Biologics | 73.52T |
Hyundai Motor Company | 47.53T |
Hanwha Aerospace | 45.43T |
HD Hyundai Heavy Industries | 42.34T |
Doosan Enerbility | 41.95T |